Vol 2, No 3 (September 12, 2013): Translational Andrology and Urology (Prostate Cancer)

Preface

Preface
Jer-Tsong Hsieh, Ganesh Raj
Translational Andrology and Urology  
2013;
2
(3)
:121
.

Review Articles

Current clinical challenges in prostate cancer
Jonathan L. Silberstein, Sumanta Kumar Pal, Brian Lewis, Oliver Sartor
Translational Andrology and Urology  
2013;
2
(3)
:122-136
.
Androgen receptor gene mutation, rearrangement, polymorphism
Kurtis Eisermann, Dan Wang, Yifeng Jing, Laura E. Pascal, Zhou Wang
Translational Andrology and Urology  
2013;
2
(3)
:137-147
.
Androgen receptor epigenetics
Changmeng Cai, Xin Yuan, Steven P. Balk
Translational Andrology and Urology  
2013;
2
(3)
:148-157
.
Androgen receptor genomic regulation
Hong-Jian Jin, Jung Kim, Jindan Yu
Translational Andrology and Urology  
2013;
2
(3)
:158-177
.
Decoding the androgen receptor splice variants
Changxue Lu, Jun Luo
Translational Andrology and Urology  
2013;
2
(3)
:178-186
.
Androgen receptor-mediated non-genomic regulation of prostate cancer cell proliferation
Ross S. Liao, Shihong Ma, Lu Miao, Rui Li, Yi Yin, Ganesh V. Raj
Translational Andrology and Urology  
2013;
2
(3)
:187-196
.
Translating insights of AR signaling from mouse models
Brett S. Carver
Translational Andrology and Urology  
2013;
2
(3)
:197-201
.
Epithelial mesenchymal transition (EMT) in prostate growth and tumor progression
Campbell M. Grant, Natasha Kyprianou
Translational Andrology and Urology  
2013;
2
(3)
:202-211
.
Steroid hormone synthetic pathways in prostate cancer
Elahe A. Mostaghel
Translational Andrology and Urology  
2013;
2
(3)
:212-227
.
The role of microRNAs in prostate cancer progression
U-Ging Lo, Diane Yang, Jer-Tsong Hsieh
Translational Andrology and Urology  
2013;
2
(3)
:228-241
.
Cancer stem cells in prostate cancer
Felix Moltzahn, George N. Thalmann
Translational Andrology and Urology  
2013;
2
(3)
:242-253
.
Near-infrared fluorescence and nuclear imaging and targeting of prostate cancer
Jason Wu, Dongfeng Pan, Leland W.K. Chung
Translational Andrology and Urology  
2013;
2
(3)
:254-264
.
Novel non-AR therapeutic targets in castrate resistant prostate cancer
Paul J. Toren, Martin E. Gleave
Translational Andrology and Urology  
2013;
2
(3)
:265-277
.

Disclosure:

The focused issue “Prostate Cancer” was commissioned by the editorial office, Translational Andrology and Urology without any sponsorship or funding. Jer-Tsong Hsieh and Ganesh Raj served as the unpaid Guest Editors for the focused issue.